[HTML] from 171.66.121.246SA Giralt, M Horowitz, D Weisdorf… - Journal of Clinical …, 2011 - 171.66.121.246 ... Previous Section. REFERENCES. ↵: Dansey R. (2000) Myelodysplasia. Curr Opin Oncol 12:13–21. ... (2002) Randomized controlled trial of azacitidine in patients with myelodysplastic syndrome: A study of the Cancer and Leukemia Group B. J Clin Oncol 20:2429–2440. ... Related articles - All 6 versions
[PDF] from hematologylibrary.orgKA McGowan, WW Pang, R Bhardwaj… - …, 2011 - bloodjournal.hematologylibrary.org ... Running title: Ribosomal protein mutations in myelodysplasia... Reduced gene dosage of ribosomal protein subunits has been implicated in 5q- myelodysplasticsyndrome and Diamond Blackfan anemia, but the cellular and pathophysiologic defects associated with these ... View as HTML
SA McClintock-Treep, RC Briggs… - American journal of …, 2011 - ajcp.ascpjournals.org Quantitative Assessment of Myeloid Nuclear Differentiation Antigen Distinguishes MyelodysplasticSyndrome From Normal Bone Marrow. ... Cited by 2 - Related articles - All 4 versions
JB Zeldis - US Patent 7,863,297, 2011 - Google Patents ... Rajapaksa et al., 1996, Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells ... ing stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes," Blood ... r-HuEpo in the treatment of anaemia related to myelodysplasia (MDS)," Br ... Related articles - All 4 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
